Happy Thanksgiving! Save 50% on Your MarketBeat All Access Subscription.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,963.94 (-1.54%)
DOW   33,849.46 (-1.45%)
QQQ   282.88 (-1.41%)
AAPL   144.49 (-2.44%)
MSFT   241.12 (-2.57%)
META   108.74 (-2.40%)
GOOGL   96.05 (-1.45%)
AMZN   94.10 (+0.74%)
TSLA   183.03 (+0.09%)
NVDA   158.23 (-2.75%)
NIO   10.13 (-0.39%)
BABA   75.80 (+0.40%)
AMD   73.13 (-2.68%)
T   18.79 (-1.73%)
MU   55.74 (-4.57%)
CGC   3.41 (-6.83%)
F   13.73 (-2.49%)
GE   85.49 (-3.01%)
DIS   95.70 (-3.21%)
AMC   7.36 (-2.00%)
PYPL   79.88 (-0.25%)
PFE   49.58 (+0.75%)
NFLX   281.33 (-1.47%)
S&P 500   3,963.94 (-1.54%)
DOW   33,849.46 (-1.45%)
QQQ   282.88 (-1.41%)
AAPL   144.49 (-2.44%)
MSFT   241.12 (-2.57%)
META   108.74 (-2.40%)
GOOGL   96.05 (-1.45%)
AMZN   94.10 (+0.74%)
TSLA   183.03 (+0.09%)
NVDA   158.23 (-2.75%)
NIO   10.13 (-0.39%)
BABA   75.80 (+0.40%)
AMD   73.13 (-2.68%)
T   18.79 (-1.73%)
MU   55.74 (-4.57%)
CGC   3.41 (-6.83%)
F   13.73 (-2.49%)
GE   85.49 (-3.01%)
DIS   95.70 (-3.21%)
AMC   7.36 (-2.00%)
PYPL   79.88 (-0.25%)
PFE   49.58 (+0.75%)
NFLX   281.33 (-1.47%)
S&P 500   3,963.94 (-1.54%)
DOW   33,849.46 (-1.45%)
QQQ   282.88 (-1.41%)
AAPL   144.49 (-2.44%)
MSFT   241.12 (-2.57%)
META   108.74 (-2.40%)
GOOGL   96.05 (-1.45%)
AMZN   94.10 (+0.74%)
TSLA   183.03 (+0.09%)
NVDA   158.23 (-2.75%)
NIO   10.13 (-0.39%)
BABA   75.80 (+0.40%)
AMD   73.13 (-2.68%)
T   18.79 (-1.73%)
MU   55.74 (-4.57%)
CGC   3.41 (-6.83%)
F   13.73 (-2.49%)
GE   85.49 (-3.01%)
DIS   95.70 (-3.21%)
AMC   7.36 (-2.00%)
PYPL   79.88 (-0.25%)
PFE   49.58 (+0.75%)
NFLX   281.33 (-1.47%)
S&P 500   3,963.94 (-1.54%)
DOW   33,849.46 (-1.45%)
QQQ   282.88 (-1.41%)
AAPL   144.49 (-2.44%)
MSFT   241.12 (-2.57%)
META   108.74 (-2.40%)
GOOGL   96.05 (-1.45%)
AMZN   94.10 (+0.74%)
TSLA   183.03 (+0.09%)
NVDA   158.23 (-2.75%)
NIO   10.13 (-0.39%)
BABA   75.80 (+0.40%)
AMD   73.13 (-2.68%)
T   18.79 (-1.73%)
MU   55.74 (-4.57%)
CGC   3.41 (-6.83%)
F   13.73 (-2.49%)
GE   85.49 (-3.01%)
DIS   95.70 (-3.21%)
AMC   7.36 (-2.00%)
PYPL   79.88 (-0.25%)
PFE   49.58 (+0.75%)
NFLX   281.33 (-1.47%)

INVO Bioscience - INVO Stock Forecast, Price & News

$0.98
-0.04 (-3.44%)
(As of 11/28/2022 03:50 PM ET)
Add
Compare
Today's Range
$0.99
$1.00
50-Day Range
$1.00
$1.54
52-Week Range
$0.63
$4.06
Volume
200 shs
Average Volume
36,103 shs
Market Capitalization
$11.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.50

INVO Bioscience MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
150.0% Upside
$2.50 Price Target
Short Interest
Healthy
0.49% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.65) to ($0.30) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.26 out of 5 stars

Medical Sector

371st out of 1,040 stocks

Surgical & Medical Instruments Industry

43rd out of 103 stocks

INVO stock logo

About INVO Bioscience (NASDAQ:INVO) Stock

INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

Receive INVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for INVO Bioscience and its competitors with MarketBeat's FREE daily newsletter.

INVO Stock News Headlines

INVO Bioscience launches INVOcell in Malaysia
Recap: INVO Bioscience Q2 Earnings
INVO Bioscience, Inc. (INVO)
INVO Bioscience: Q1 Earnings Insights
See More Headlines
Receive INVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for INVO Bioscience and its competitors with MarketBeat's FREE daily newsletter.

INVO Company Calendar

Last Earnings
11/15/2021
Today
11/28/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
3/30/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:INVO
Fax
N/A
Employees
10
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$2.50
High Stock Price Forecast
$3.00
Low Stock Price Forecast
$2.00
Forecasted Upside/Downside
+153.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$-6,660,000.00
Net Margins
-230.18%
Pretax Margin
-223.38%

Debt

Sales & Book Value

Annual Sales
$4.16 million
Book Value
$0.62 per share

Miscellaneous

Free Float
10,909,000
Market Cap
$11.99 million
Optionable
Not Optionable
Beta
0.15

Key Executives

  • Mr. Steven M. Shum (Age 51)
    CEO & Director
    Comp: $297.5k
  • Mr. Andrea GorenMr. Andrea Goren (Age 55)
    Chief Financial Officer
    Comp: $247.73k
  • Mr. Michael Jos. Campbell (Age 64)
    COO & VP of Bus. Devel.
    Comp: $330k
  • Dr. Kevin Doody M.D. (Age 63)
    Medical Director & Director
    Comp: $25k
  • Mr. Bojan Mitrovic Ph.D.
    Director of Sales US
  • Dr. Barbara Levy F.A.C.S.
    FACOG, M.D., Sr. VP of Global Clinical Integration
  • Mr. Chris Myer
    Sr. VP of Bus. Devel. of Americas
  • Mr. Robert Joseph Bowdring Jr. (Age 64)
    Treasurer & Sec.
  • Ms. Terah Krigsvold
    Controller
  • Ms. Lori Marzilli-Kahler
    VP of Global Operations













INVO Stock - Frequently Asked Questions

Should I buy or sell INVO Bioscience stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for INVO Bioscience in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" INVO shares.
View INVO analyst ratings
or view top-rated stocks.

What is INVO Bioscience's stock price forecast for 2023?

3 analysts have issued twelve-month price objectives for INVO Bioscience's stock. Their INVO share price forecasts range from $2.00 to $3.00. On average, they expect the company's stock price to reach $2.50 in the next year. This suggests a possible upside of 153.8% from the stock's current price.
View analysts price targets for INVO
or view top-rated stocks among Wall Street analysts.

How have INVO shares performed in 2022?

INVO Bioscience's stock was trading at $3.33 on January 1st, 2022. Since then, INVO shares have decreased by 70.4% and is now trading at $0.9850.
View the best growth stocks for 2022 here
.

When is INVO Bioscience's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 30th 2023.
View our INVO earnings forecast
.

How were INVO Bioscience's earnings last quarter?

INVO Bioscience, Inc. (NASDAQ:INVO) released its quarterly earnings results on Monday, November, 15th. The company reported ($0.24) EPS for the quarter, missing analysts' consensus estimates of ($0.20) by $0.04. The business had revenue of $0.22 million for the quarter, compared to analysts' expectations of $0.25 million. INVO Bioscience had a negative net margin of 230.18% and a negative trailing twelve-month return on equity of 183.08%. During the same quarter in the previous year, the firm earned ($0.36) earnings per share.

What is INVO Bioscience's stock symbol?

INVO Bioscience trades on the NASDAQ under the ticker symbol "INVO."

Who are INVO Bioscience's major shareholders?

INVO Bioscience's stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (3.02%) and Ieq Capital LLC (0.41%). Insiders that own company stock include Andrea Goren, Awm Investment Company, Inc, Matthew K Szot, Michael Jos Campbell and Steve Shum.
View institutional ownership trends
.

How do I buy shares of INVO Bioscience?

Shares of INVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is INVO Bioscience's stock price today?

One share of INVO stock can currently be purchased for approximately $0.99.

How much money does INVO Bioscience make?

INVO Bioscience (NASDAQ:INVO) has a market capitalization of $11.99 million and generates $4.16 million in revenue each year.

How can I contact INVO Bioscience?

INVO Bioscience's mailing address is 5582 BROADCAST COURT, SARASOTA FL, 34240. The official website for the company is www.invobioscience.com. The company can be reached via phone at (978) 878-9505 or via email at info@invobio.com.

This page (NASDAQ:INVO) was last updated on 11/28/2022 by MarketBeat.com Staff